EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION
Services
How to use the platform
Build a poster
MANAGE ORDERS
FAQs
Contact
HOMEPAGE
Virtual Poster Gallery
PrintingOnline for Collection on-site
Accredited Training
DOI - Digital Object Identifier
What is PosterSessionOnline?
How to send your poster
How to visit the Virtual Poster Gallery
How to build a poster
How to reduce a poster to less than 2 Mb
PosterSessionOnline Image Editor
How to build a poster with our templates
How to work with a template
Templates and instructions
Discussion forum -
49th ERA-EDTA Congress
Topic -
Extracorporeal dialysis: techniques and adequacy
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
Poster:
500
Visits:
778
Title:
REACTIVE OXYGEN METABOLITES (ROMS) ARE ASSOCIATED WITH CARDIOVASCULAR DISEASE AND NEW CARDIOVASCULAR EVENTS IN CHRONIC HEMODIALYSIS PATIENTS
Authors:
Maurizio Bossola ,
Centre:
Catholic University
You must be registered to reply or comment.
REACTIVE OXYGEN METABOLITES (ROMS) ARE ASSOCIATED WITH CARDIOVASCULAR DISEASE AND NEW CARDIOVASCULAR EVENTS IN CHRONIC HEMODIALYSIS PATIENTS
Maurizio Bossola
Thread initiator
Subspeciality
Reg:
4/19/2009 12:02:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.
Comment added on 4/24/2012 9:48:00 AM
You must be registered to reply or comment.
Most viewed poster for this congress
Poster:
424
Visits:
2891
Title:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors:
Giuseppe Coppolino ,
Centre:
Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy
Poster most viewed in this topic
Poster:
410
Visits:
1221
Title:
INSTRUCTION FOR USE OF DIALYZERS IN POST DILUTION ON LINE HEMODIAFILTRATION
Authors:
POTIER Jacky ,
Centre:
CHPC Cherbourg
View Poster Gallery
Back to congress home
Other Congresses
About us
|
Terms and Conditions
|
Special Access